| Yasir Hatahet, MD | |
|
420 E Division St, Fond Du Lac, WI 54935-4560 | |
| (920) 926-8485 | |
| Not Available |
| Full Name | Yasir Hatahet |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 45 Years |
| Location | 420 E Division St, Fond Du Lac, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407837537 | NPI | - | NPPES |
| 34447900 | Medicaid | WV | |
| 367884049005 | Other | WI | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 46206 (Wisconsin) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 46206 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Agnes Hospital | Fond du lac, WI | Hospital |
| Waupun Memorial Hospital | Waupun, WI | Hospital |
| Ripon Medical Center | Ripon, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Agnesian Healthcare Inc | 1658289624 | 319 |
News Archive
In recognition of Veteran's Day this November Penn Medicine proudly sponsors Joining Forces - a national initiative to heighten awareness about the health needs of our nation's veterans, service members and families, and elevate the role that medical schools, nursing schools and teaching hospitals play in serving their community.
Cystic fibrosis (CF), a chronic disease that clogs the lungs and leads to life-threatening lung infections, is caused by a genetic defect in a chloride channel called cystic fibrosis transmembrane conductase regulator.
Genentech, Inc. a wholly-owned member of the Roche Group, and Biogen Idec announced today that the companies received a Complete Response from the U.S. Food and Drug Administration (FDA) for a supplemental Biologics License Application (sBLA) for Rituxan (rituximab) plus methotrexate (MTX) in patients with moderately-to-severely active rheumatoid arthritis (RA) who no longer respond to treatment with a disease modifying antirheumatic drug (DMARD), including MTX.
A survey of nurses anaesthetists in Sweden identified difficulties in preparing children for surgery but also found that when the hospital and the staff were flexible in their approaches, the children's anxiety could be reduced. These approaches included varying the operation schedule, provided it do not create risk to the child, and pre-surgical visits with operating staff.
A major discovery about an enzyme's structure has opened a window on understanding DNA repair. Scientists at Duke University Medical Center have determined the structure of a nuclease that will help scientists to understand several DNA repair pathways, a welcome development for cancer research.
› Verified 8 days ago
| Entity Name | Agnesian Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346228541 PECOS PAC ID: 1658289624 Enrollment ID: O20031104000263 |
News Archive
In recognition of Veteran's Day this November Penn Medicine proudly sponsors Joining Forces - a national initiative to heighten awareness about the health needs of our nation's veterans, service members and families, and elevate the role that medical schools, nursing schools and teaching hospitals play in serving their community.
Cystic fibrosis (CF), a chronic disease that clogs the lungs and leads to life-threatening lung infections, is caused by a genetic defect in a chloride channel called cystic fibrosis transmembrane conductase regulator.
Genentech, Inc. a wholly-owned member of the Roche Group, and Biogen Idec announced today that the companies received a Complete Response from the U.S. Food and Drug Administration (FDA) for a supplemental Biologics License Application (sBLA) for Rituxan (rituximab) plus methotrexate (MTX) in patients with moderately-to-severely active rheumatoid arthritis (RA) who no longer respond to treatment with a disease modifying antirheumatic drug (DMARD), including MTX.
A survey of nurses anaesthetists in Sweden identified difficulties in preparing children for surgery but also found that when the hospital and the staff were flexible in their approaches, the children's anxiety could be reduced. These approaches included varying the operation schedule, provided it do not create risk to the child, and pre-surgical visits with operating staff.
A major discovery about an enzyme's structure has opened a window on understanding DNA repair. Scientists at Duke University Medical Center have determined the structure of a nuclease that will help scientists to understand several DNA repair pathways, a welcome development for cancer research.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yasir Hatahet, MD 420 E Division St, Fond Du Lac, WI 54935-4560 Ph: (920) 926-8340 | Yasir Hatahet, MD 420 E Division St, Fond Du Lac, WI 54935-4560 Ph: (920) 926-8485 |
News Archive
In recognition of Veteran's Day this November Penn Medicine proudly sponsors Joining Forces - a national initiative to heighten awareness about the health needs of our nation's veterans, service members and families, and elevate the role that medical schools, nursing schools and teaching hospitals play in serving their community.
Cystic fibrosis (CF), a chronic disease that clogs the lungs and leads to life-threatening lung infections, is caused by a genetic defect in a chloride channel called cystic fibrosis transmembrane conductase regulator.
Genentech, Inc. a wholly-owned member of the Roche Group, and Biogen Idec announced today that the companies received a Complete Response from the U.S. Food and Drug Administration (FDA) for a supplemental Biologics License Application (sBLA) for Rituxan (rituximab) plus methotrexate (MTX) in patients with moderately-to-severely active rheumatoid arthritis (RA) who no longer respond to treatment with a disease modifying antirheumatic drug (DMARD), including MTX.
A survey of nurses anaesthetists in Sweden identified difficulties in preparing children for surgery but also found that when the hospital and the staff were flexible in their approaches, the children's anxiety could be reduced. These approaches included varying the operation schedule, provided it do not create risk to the child, and pre-surgical visits with operating staff.
A major discovery about an enzyme's structure has opened a window on understanding DNA repair. Scientists at Duke University Medical Center have determined the structure of a nuclease that will help scientists to understand several DNA repair pathways, a welcome development for cancer research.
› Verified 8 days ago
Balvindar S Sareen, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 315-637-7800 Fax: 315-637-7808 | |
Allen C. Foster, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 715-235-5531 Fax: 715-233-7645 | |
Jay R Muller, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 420 E Division St, Fond Du Lac, WI 54935 Phone: 920-926-8420 Fax: 920-926-8913 | |
Dana I Vasquez, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 420 E Division St, Fond Du Lac, WI 54935 Phone: 920-926-8420 | |
Adam P Karewicz, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 420 E Division St, Fond Du Lac, WI 54935 Phone: 920-926-8420 | |
Punit Kumar, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 420 E Division St, Fond Du Lac Regional Clinic, Fond Du Lac, WI 54935 Phone: 920-926-8420 | |
Dr. Steven Gregory Meress, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 180 Knights Way, Fond Du Lac, WI 54935 Phone: 920-922-5433 Fax: 920-273-0480 |